Merck stock analysts called for earnings of $6.50 per share and $52 billion in sales. Merck stock tumbled Thursday as the coronavirus pandemic contributed to a sluggish first quarter, though the company's 2021 outlook remained strong. [Extracted from the article]
Copyright of Investors Business Daily is the property of Investor's Business Daily and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
